Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic

Objective: We aimed to use SARS-CoV-2 antibody tests to assess the asymptomatic seroprevalence of individuals in high-risk hospital cohorts who's previous COVID-19 exposure is unknown; staff, and patients requiring haemodialysis or chemotherapy after the first wave. Methods: In a single Center,...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Kelly, Brendan, McLaughlin, Ronan, O'Doherty, Roseann, Carroll, Hailey, Murray, Roisin, Dilworth, Rachel, Corkery, Laura, Cotter, Aoife G., McGinty, Tara, Muldoon, Eavan G., Cullen, Walter, Avramovic, Gordana, Sheehan, Gerard, Sadlier, Denise, Higgins, Michaela, O'Gorman, Peter, Doran, Peter, Inzitari, Rosanna, Holden, Sinead, O'Meara, Yvonne, Ennis, Sean, Lambert, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427142/
https://www.ncbi.nlm.nih.gov/pubmed/34513853
http://dx.doi.org/10.3389/fmed.2021.642318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427142/
https://www.ncbi.nlm.nih.gov/pubmed/34513853
http://dx.doi.org/10.3389/fmed.2021.642318

Ejemplares similares